| Baker Bros. Advisors Lp |
Director, 10%+ Owner |
$1.72B |
|
|
Mar 31, 2025 |
| Herve Hoppenot |
Chairman / CEO, Director, President |
$34.1M |
|
|
Apr 1, 2025 |
| Pablo J. Cagnoni |
President, R&D |
$14.2M |
|
|
Jan 17, 2025 |
| Christiana Stamoulis |
EVP & Chief Financial Officer |
$7.82M |
|
|
Apr 1, 2025 |
| Steven H. Stein |
EVP & Chief Medical Officer |
$7.58M |
-$1.6M |
-17.5% |
Apr 1, 2025 |
| Paula J. Swain |
EVP, Human Resources |
$6.5M |
|
|
Apr 1, 2025 |
| Wenqing Yao |
EVP, Head of Discovery Chem |
$6.06M |
|
|
Jul 2, 2021 |
| Michael James Morrissey |
EVP, Head of Tech. Operations |
$5.22M |
|
|
Apr 1, 2025 |
| Maria E. Pasquale |
EVP & General Counsel |
$4.29M |
|
|
Jul 14, 2023 |
| Dashyant Dhanak |
EVP & Chief Scientific Officer |
$3.63M |
|
|
Jul 14, 2023 |
| Barry P. Flannelly |
EVP & General Manager US |
$3.61M |
-$3.36M |
-48.1% |
Apr 1, 2025 |
| Mohamed Khairie Issa |
EVP, Head of US Oncology |
$3.36M |
|
|
Jan 6, 2025 |
| Vijay K. Iyengar |
Evp, Gmapps |
$3.2M |
-$1.55M |
-32.6% |
Apr 1, 2025 |
| Lee Heeson |
EVP, Head of Incyte Intl |
$2.38M |
|
|
Jan 31, 2025 |
| Jonathan Elliott Dickinson |
EVP, General Manager, Europe |
$2.27M |
-$527K |
-18.8% |
Sep 12, 2024 |
| Paul Trower |
Principal Accounting Officer |
$1.98M |
|
|
Jan 19, 2022 |
| Sheila A. Denton |
EVP & General Counsel |
$1.81M |
-$1.08M |
-37.5% |
Mar 4, 2025 |
| Thomas Tray |
Principal Accounting Officer |
$1.62M |
-$216K |
-11.8% |
Jan 17, 2025 |
| Paul J. Clancy |
Director |
$1.22M |
|
|
Mar 31, 2025 |
| Jean Jacques Bienaime |
Director |
$1.1M |
|
|
Jun 12, 2024 |
| Wendy L. Dixon |
Director |
$1.09M |
|
|
Mar 31, 2022 |
| Edmund Harrigan |
Director |
$1.06M |
|
|
Mar 31, 2025 |
| Jacqualyn Fouse |
Director |
$1.01M |
|
|
Jun 12, 2024 |
| Katherine A. High |
Director |
$649K |
|
|
Jun 12, 2024 |
| Matteo Trotta |
EVP, GM, Dermatology US |
$617K |
|
|
Mar 25, 2025 |
| Otis W. Brawley |
Director |
$524K |
|
|
Jun 12, 2024 |
| Susanne Schaffert |
Director |
$343K |
|
|
Jun 12, 2024 |